220 related articles for article (PubMed ID: 29654631)
21. The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies.
Sadeghi M; Khodakarami A; Ahmadi A; Fathi M; Gholizadeh Navashenaq J; Mohammadi H; Yousefi M; Hojjat-Farsangi M; Movasaghpour Akbari AA; Jadidi-Niaragh F
Expert Opin Ther Targets; 2022 Dec; 26(12):1057-1071. PubMed ID: 36683579
[TBL] [Abstract][Full Text] [Related]
22. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
23. Anthropometric characteristics, physical activity and risk of hematological malignancies: A systematic review and meta-analysis of cohort studies.
Psaltopoulou T; Sergentanis TN; Ntanasis-Stathopoulos I; Tzanninis IG; Riza E; Dimopoulos MA
Int J Cancer; 2019 Jul; 145(2):347-359. PubMed ID: 30614529
[TBL] [Abstract][Full Text] [Related]
24. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades.
Thein MS; Ershler WB; Jemal A; Yates JW; Baer MR
Cancer; 2013 Aug; 119(15):2720-7. PubMed ID: 23633441
[TBL] [Abstract][Full Text] [Related]
25. Increasing survival from leukemia among adolescents and adults in Canada: A closer look.
Ellison LF
Health Rep; 2016 Jul; 27(7):19-26. PubMed ID: 27439000
[TBL] [Abstract][Full Text] [Related]
26. A population-based analysis of hematological malignancies from a French-West-Indies cancer registry's data (2009-2018).
Houpert R; Almont T; Belahreche R; Faro M; Okouango J; Vestris M; Macni J; Pierre-Louis O; Montabord C; Beaubrun-Renard M; Soumah N; Boisseau M; Véronique-Baudin J; Joachim C
BMC Cancer; 2023 Dec; 23(1):1197. PubMed ID: 38057723
[TBL] [Abstract][Full Text] [Related]
27. Pattern of hematological malignancies in adolescents and young adults in Bangladesh.
Hasan MM; Raheem E; Sultana TA; Hossain MS
Cancer Epidemiol; 2017 Dec; 51():109-112. PubMed ID: 29121606
[TBL] [Abstract][Full Text] [Related]
28. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database.
Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP
Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological Findings of Haematological Malignancies in Hospital Admitted Patients.
Islam AS; Ara ZG; Bhuiyan GR; Khan AU; Khan MM
Mymensingh Med J; 2021 Jan; 30(1):28-34. PubMed ID: 33397847
[TBL] [Abstract][Full Text] [Related]
30. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Warlick ED; Tomblyn M; Cao Q; Defor T; Blazar BR; Macmillan M; Verneris M; Wagner J; Dusenbery K; Aurora M; Bachanova V; Brunstein C; Burns L; Cooley S; Kaufman D; Majhail NS; McClune B; McGlave P; Miller J; Oran B; Slungaard A; Vercellotti G; Weisdorf DJ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1025-32. PubMed ID: 21047561
[TBL] [Abstract][Full Text] [Related]
31. Hospital discharge records as data source to monitor epidemiologic indicators of hematologic malignancies in Abruzzo.
Vitullo F; Di Biagio K; Murgano A; Di Bartolomeo P
Tumori; 2016 Jun; 2016(3):258-63. PubMed ID: 26917409
[TBL] [Abstract][Full Text] [Related]
32. Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975-2016.
Lewis DR; Siembida EJ; Seibel NL; Smith AW; Mariotto AB
Cancer; 2021 Nov; 127(22):4277-4286. PubMed ID: 34308557
[TBL] [Abstract][Full Text] [Related]
33. Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.
Mo X; Zhou M; Yan H; Chen X; Wang Y
Cancer Med; 2021 Aug; 10(15):5338-5346. PubMed ID: 34189859
[TBL] [Abstract][Full Text] [Related]
34. Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype.
Yin X; Hu X; Tong H; You L
Ther Adv Chronic Dis; 2023; 14():20406223231173891. PubMed ID: 37360415
[TBL] [Abstract][Full Text] [Related]
35. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological Trends of Haematological Malignancies in Belgium 2004-2018: Older Patients Show the Greatest Improvement in Survival.
Henau K; Tambuyzer T; Van Gool B; Van Eycken L; Poirel HA
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686664
[TBL] [Abstract][Full Text] [Related]
37. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
38. Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.
Ye X; Mahmud S; Skrabek P; Lix L; Johnston JB
BMJ Open; 2017 Jul; 7(7):e015106. PubMed ID: 28716788
[TBL] [Abstract][Full Text] [Related]
39. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.
Elidrissi Errahhali M; Elidrissi Errahhali M; Boulouiz R; Ouarzane M; Bellaoui M
BMC Cancer; 2016 Feb; 16():159. PubMed ID: 26915519
[TBL] [Abstract][Full Text] [Related]
40. Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period.
Utuama O; Mukhtar F; Pham YT; Dabo B; Manani P; Moser J; Michael-Asalu A; Tran CT; Le LC; Le TV; Vu KT; Park JY; Boffetta P; Zheng W; Shu XO; Luu HN
PLoS One; 2019; 14(8):e0220864. PubMed ID: 31425527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
